Utama › Penyakit Paru-paru › Texas › Houston
Kajian klinikal Penyakit Paru-paru di Houston, TX
15 kajian untuk Penyakit Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of COVID-19 Vaccine(s) in Children and Adults
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- DM Clinical Research-Cyfair, Houston
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Mengambil pesertaFasa 3
- Memorial Hermann Hospital TMC, Houston
- The University of Texas Health Science Center at Houston, Houston
- UT Physicians, Houston
- dan 4 lagi
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Mengambil pesertaFasa 3
- Cockrell Center for Advanced Therapeutics, Houston
- Houston Methodist - Transplant Center, Houston
- Houston Methodist Hospital, Houston
- dan 4 lagi
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Mengambil pesertaFasa 2
- Baylor College of Medicine Medical Center, Houston
American Lung Association (ALA) Lung Health Cohort
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Baylor College of Medicine, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- MD Anderson, Houston
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Mengambil pesertaFasa 2
- Greater Heights & Memorial Pulmonary and Sleep, Houston
- Houston Pulmonary Sleep and Allergy Associates, Houston
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Site 1005, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Mengambil pesertaFasa 3
- GSK Investigational Site, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Mengambil pesertaFasa 2
- Baylor College of Medicine, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Mengambil pesertaFasa 2
- Clinical Research Site, Houston
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Mengambil pesertaFasa 2
- University of Texas MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Mengambil peserta
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Kajian Penyakit Paru-paru di bandar lain
- Boston, MA14 kajian
- Durham, NC13 kajian
- New York City, NY12 kajian
- Pittsburgh, PA11 kajian
- Dallas, TX10 kajian
- Nashville, TN10 kajian
- Columbus, OH10 kajian
- Los Angeles, CA10 kajian
- Washington, DC10 kajian
- Miami, FL10 kajian
- Ann Arbor, MI10 kajian
- Chicago, IL9 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser (semua jenis)121 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.